255 related articles for article (PubMed ID: 19325240)
1. Intravenous iron sucrose changes the intraperitoneal homeostasis.
Breborowicz A; Połubinska A; Kupczyk M; Wanic-Kossowka M; Oreopoulos DG
Blood Purif; 2009; 28(1):53-8. PubMed ID: 19325240
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal effects of intravenous iron sucrose administration in rats.
Breborowicz A; Polubinska A; Breborowicz M; Simon M; Wanic-Kossowska M; Oreopoulos DG
Transl Res; 2007 Jun; 149(6):304-9. PubMed ID: 17543848
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine modulates effect of the iron isomaltoside on peritoneal mesothelial cells.
Misian M; Baum E; Breborowicz A
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991316
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
[TBL] [Abstract][Full Text] [Related]
5. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
Malik AR; Little MA; Henriksson M; Tam FW; Brown EA
J Nephrol; 2007; 20(3):340-9. PubMed ID: 17557268
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells.
Chang JM; Lin SP; Lai YH; Chen HC
Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374
[TBL] [Abstract][Full Text] [Related]
7. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
8. Effect of the dialysate effluent from CAPD patients on peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Patrikarea A; Martis L; Oreopoulos DG
Adv Perit Dial; 1994; 10():230-4. PubMed ID: 7999835
[TBL] [Abstract][Full Text] [Related]
9. Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells.
Breborowicz A; Pyda M; Moberly J; Martis L; Oreopoulos D
Am J Nephrol; 2004; 24(3):316-21. PubMed ID: 15148458
[TBL] [Abstract][Full Text] [Related]
10. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
11. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
12. Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion.
Styszynski A; Podkowka R; Wieczorowska-Tobis K; Kwiatkowska B; Ksiazek K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2002; 18():21-5. PubMed ID: 12402581
[TBL] [Abstract][Full Text] [Related]
13. Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids.
Yamamoto T; Tomo T; Okabe E; Namoto S; Suzuki K; Hirao Y
Nephrol Dial Transplant; 2009 May; 24(5):1436-42. PubMed ID: 19033251
[TBL] [Abstract][Full Text] [Related]
14. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
[TBL] [Abstract][Full Text] [Related]
16. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Wisniewska J; Tam P; French I; Wu G
Adv Perit Dial; 1998; 14():31-5. PubMed ID: 10649686
[TBL] [Abstract][Full Text] [Related]
17. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
[TBL] [Abstract][Full Text] [Related]
18. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
Santamaría B; Ucero AC; Reyero A; Selgas R; Ruiz-Ortega M; Catalán M; Egido J; Ortiz A
Nephrol Dial Transplant; 2008 Oct; 23(10):3307-15. PubMed ID: 18524790
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
